Approval · Notice of Compliance 9831 · 2008
ZEVALIN: Notice of Compliance 9831
Issued October 14, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9831
- Date
- October 14, 2008
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Radiopharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in manufacturing - new faciltiy
- Therapeutic class
- Therapeutic radiopharmaceutical
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZEVALIN | Not yet assigned | — |
Medicinal ingredients
- IBRITUMOMAB TIUXETAN 3.2 MG per 2ML